As the psoriasis landscape shifts toward targeted biologics and innovative topicals, DelRicht Research offers sponsors a premier partnership built on operational excellence. With 14 psoriasis trials completed, 130+ participants enrolled, and 8 experienced sites nationwide, our embedded network delivers high-quality data and rapid enrollment for even the most complex dermatology protocols.

Trusted Investigators Nationwide

Our success is driven by our network of 9 specialized dermatology investigators with more than 187 years of combined clinical experience. Beyond standard trial oversight, our principal investigators are subject matter experts in the complexities of psoriasis, ranging from moderate-to-severe plaque psoriasis cases to the nuances of rarer disease variants.

This depth of knowledge is critical when navigating the intricacies of dermatology research. Our investigators are masters of complex protocol requirements, including managing washout periods for previous biologics and ensuring precise assessment in difficult-to-treat areas like the scalp, nails, and palms. While our focus on psoriasis is sharp, our investigators’ expertise extends across the dermatological spectrum, including atopic dermatitis, vitiligo, acne, HS, and alopecia, ensuring a holistic approach to patient skin health throughout the study lifecycle.

Integrated Patient Support for Retention and Compliance

Psoriasis trials often place a significant administrative and lifestyle burden on participants. Success hinges on more than just the initial enrollment; it requires the long-term adherence of patients to daily diaries, ePRO reporting, and strict medication schedules. DelRicht’s dedicated, full-time site staff act as the bridge between complex protocols and patient success.

By providing tailored psoriasis education and proactive flare management, our teams foster a supportive environment that encourages retention. We implement attentive monitoring for daily diaries to ensure data integrity, helping sponsors capture a clear, real-world picture of treatment efficacy. This “patient-first” infrastructure is a key reason why DelRicht Research consistently delivers reliable results in long-term Phase I-IV studies.

Network Capabilities at Scale

With 8 fully equipped dermatology sites nationwide, DelRicht offers a scalable infrastructure designed for speed and precision. Our sites are strategically embedded within high-volume physician clinics, allowing us to move from site selection to “First Patient In” with industry-leading efficiency. Each location is outfitted with:

– Secure Investigational Product (IP) storage
– Access to reliable local laboratories
– Detail-oriented specialty care providers
– Streamlined and centralized operational models that minimize startup delays

Proven Access to Diverse and Priority Cohorts

One of the most significant challenges in modern psoriasis research is reaching underserved populations and securing specific patient cohorts. DelRicht excels in this area, maintaining an average diversity rate of 45%+ across our sites. By embedding our research facilities within diverse communities, we ensure that clinical trial data is representative of the broader patient population.

Our network provides direct access to high-value priority cohorts that sponsors frequently struggle to find, including:

– Biologic-naïve patients ready for first-line innovation
– Inadequate responders seeking alternative therapies
– Patients with involvement in high-impact, difficult-to-treat areas

Performance That Moves Medicine Forward

DelRicht’s track record is defined by measurable impact. In the past seven years, we have consistently ranked among the top enrollers for Phase I-IV trials, including achieving top enroller status in a recent psoriasis study. Our commitment to excellence has played a direct role in bringing new treatments to the pharmacy shelf; DelRicht has proudly supported three FDA approvals in the psoriasis space:

– UCB BIMZELX®
– Arcutis Zoryve®
– Arcutis VTAMA®

Ready to Streamline Your Next Psoriasis Trial

DelRicht Research is purpose-built to handle the challenges of modern dermatology research. By combining deep therapeutic expertise with a diverse patient reach and a proven operational model, we help sponsors move medicine forward with confidence. Whether you are launching a small study or a large-scale trial, our team is ready to deliver the enrollment success and data quality your therapy deserves.